These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 20599299

  • 1. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
    El-Azab AS, Al-Omar MA, Abdel-Aziz AA, Abdel-Aziz NI, el-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG.
    Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
    Abouzid K, Shouman S.
    Bioorg Med Chem; 2008 Aug 15; 16(16):7543-51. PubMed ID: 18678492
    [Abstract] [Full Text] [Related]

  • 3. New substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: in vitro and docking experiments.
    de Oliveira AN, Bocca CC, Carvalho JE, Ruiz AL, Silva TP, Rittner R, Hoehr NF.
    Eur J Med Chem; 2010 Sep 15; 45(9):4339-42. PubMed ID: 20627376
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM, Ashour AE.
    J Enzyme Inhib Med Chem; 2012 Aug 15; 27(4):541-5. PubMed ID: 21851213
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
    Lv PC, Wang KR, Li QS, Chen J, Sun J, Zhu HL.
    Bioorg Med Chem; 2010 Feb 15; 18(3):1117-23. PubMed ID: 20056425
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT, Yuan TT, Liu HH, Chen SF, Wu YT.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6373-7. PubMed ID: 17889528
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
    Chandregowda V, Kush AK, Chandrasekara Reddy G.
    Eur J Med Chem; 2009 Jul 15; 44(7):3046-55. PubMed ID: 18771819
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of novel 2,4'-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors.
    Abou-Seri SM.
    Eur J Med Chem; 2010 Sep 15; 45(9):4113-21. PubMed ID: 20580136
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW, Xu GJ, Wang J, Jiang XL, Li HB.
    ChemMedChem; 2013 Jun 15; 8(6):928-33. PubMed ID: 23640754
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
    Lv PC, Zhou CF, Chen J, Liu PG, Wang KR, Mao WJ, Li HQ, Yang Y, Xiong J, Zhu HL.
    Bioorg Med Chem; 2010 Jan 01; 18(1):314-9. PubMed ID: 19914835
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects.
    Antonello A, Tarozzi A, Morroni F, Cavalli A, Rosini M, Hrelia P, Bolognesi ML, Melchiorre C.
    J Med Chem; 2006 Nov 16; 49(23):6642-5. PubMed ID: 17154492
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benzothiazoles: search for anticancer agents.
    Noolvi MN, Patel HM, Kaur M.
    Eur J Med Chem; 2012 Aug 16; 54():447-62. PubMed ID: 22703845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors.
    Jin Y, Li HY, Lin LP, Tan J, Ding J, Luo X, Long YQ.
    Bioorg Med Chem; 2005 Oct 01; 13(19):5613-22. PubMed ID: 15993078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.